Skip to main content
. 2022 Jun 30;11(6):2816–2823. doi: 10.4103/jfmpc.jfmpc_2274_21

Table 4.

Distribution of child participants by selected variables and seropositivity rate

Variables Total (N=700)

Participants (n) Seropositive (n) Proportion of seropositive (%) (95% CI) Adjusted prevalence (%) 95% CI
Male 362 192 53.0 (47.7-58.3) 56.1 (50.8-61.3)
Female 338 198 58.6 (53.1-63.8) 62.1 (56.7-67.3)
1-4 years 33 14 42.4 (25.5-60.8) 45.0 (28.1-63.6)
5-9 years 153 67 43.8 (35.8-52.0) 46.4 (38.3-54.6)
10-17 years 512 309 60.3 (55.9-64.6) 63.9 (59.5-68.0)
Symptomatic 131 90 68.7 (60.0-76.5) 72.8 (64.0-79.9)
Asymptomatic 569 300 52.7 (48.5-56.9) 55.9 (51.7-60.0)
Total 700 390 55.7 (51.9-59.4) 59.0 (55.2-62.7)

CI=confidence interval